Strategic investors Avelios Medical has secured notable funding from Sequoia-led Series A and high-profile strategic investors Fresenius and SAP, signaling strong validation and potential for large-scale enterprise opportunities with healthcare providers and payors seeking modern HIS platforms.

Large health buyers Recent client acquisition includes Ukhd (Thoraxklinik Heidelberg), indicating momentum with major hospital networks; leverage this to pursue additional hospital affiliations and integrated care sites that require cloud-native, data-driven HIS solutions.

Data and AI edge The platform emphasizes fully structured treatment data, data-driven research, BI, workflow automation, and AI algorithm integration, presenting upsell potential for advanced analytics, AI-assisted clinical workflows, and research collaborations.

Growth signals Funding rounds totaling over €30M plus ongoing Series B activity reflect rapid growth and scaling capabilities, suggesting readiness for large deals, Enterprise IT modernization projects, and multi-site deployments.

Industry positioning Positioned as a next-generation, cloud-native hospital information system with modular microservices, offering a compelling value proposition against traditional HIS players and opening doors to partnerships with large healthcare groups and technology integrators.